← Browse by Condition
Medical Condition
overweight
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for overweight sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — overweight Clinical Trials
How many clinical trials are currently recruiting for overweight?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for overweight, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for overweight?
overweight research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a overweight clinical trial?
Eligibility criteria for overweight trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 2
Phase 3 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06325722
Recruiting
Enrollment
42 pts
Location
United States
Sponsor
National Institute of Diabetes...
NCT07280936 Phase 1
Recruiting
Enrollment
124 pts
Location
China
Sponsor
Beijing Suncadia Pharmaceutica...
NCT04907396
Recruiting
Enrollment
100,000 pts
Location
United States
Sponsor
Tufts University
NCT07684235 Phase 3
Recruiting
Enrollment
3,200 pts
Location
United States, Austr...
Sponsor
Amgen
NCT06672549 Phase 3
Recruiting
Enrollment
125 pts
Location
United States, Belgi...
Sponsor
Eli Lilly and Company
NCT06173778 Phase 2
Recruiting
Enrollment
197 pts
Location
United States
Sponsor
The University of Texas Health...
NCT07743450 Phase 3
Recruiting
Enrollment
1,560 pts
Location
United States, Czech...
Sponsor
Ascletis Pharma (China) Co., L...
NCT05942287
Recruiting
Enrollment
110 pts
Location
Jersey, United Kingd...
Sponsor
University of Oxford
NCT07009171 Phase 2
Recruiting
Enrollment
75 pts
Location
South Korea
Sponsor
NeuroBiogen Co., Ltd
NCT07082062
Recruiting
Enrollment
100 pts
Location
Taiwan
Sponsor
Shih Chien Huang
NCT06619041
Recruiting
Enrollment
320 pts
Location
United States
Sponsor
VA Office of Research and Deve...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology